Masahiro Kodani

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Hiroki Izumi, Shingo Matsumoto, Jie Liu et al. · Nature · 2021 · 71 citations · Full text

Medicine, Cancer Biology, Oncology +16

Loss of imprinting of PEG1/MEST in lung cancer cell lines

Hirofumi Nakanishi, Tetsuji Suda, Motonobu Katoh et al. · Oncology Reports · 2004 · 52 citations

Medicine, Cell Biology, Oncology +11

Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-? through Akt inhibition

Yasushi Shigeoka, Tadashi Igishi, Shingo Matsumoto et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Causes of death in patients with asthma and asthma–chronic obstructive pulmonary disease overlap syndrome

Akira Yamasaki, Tomoya Harada, Takehito Fukushima et al. · International Journal of COPD · 2015 · 40 citations · Full text

Medicine, Internal Medicine, Epidemiology +14

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka et al. · CHEST Journal · 2019 · 39 citations

Medicine, Oncology, Pathology +14